Monday, August 1, 2011

Big Pharma’s Falling R&D Investment Helps Small Biotechs - 07/29/2011 - The Burrill Report

BDO has a new report that examines Big Pharma's cuts to its R&D budget, and investigates the trade off between cutting internal R&D and filling the pipeline by doing deals with smaller firms.
(This is the subject of a research project that I hope to execute within the next year.)

No comments: